Company Filing History:
Years Active: 2014-2018
Title: Vladimir Voynov: Innovator in Protein Engineering
Introduction
Vladimir Voynov is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of protein engineering. With a total of 5 patents, he has developed innovative methods that enhance the stability and functionality of proteins, which are crucial in various biomedical applications.
Latest Patents
Among his latest patents, one notable invention is titled "Methods to identify macromolecule binding and aggregation prone regions in proteins and uses therefor." This invention provides methods and computational tools, based on computer simulations, that identify macromolecule binding regions and aggregation prone regions of a protein. Substitutions can then be made in these regions to engineer proteins with enhanced stability and a reduced propensity for aggregation. Another significant patent is focused on "Immunoglobulins with reduced aggregation." This disclosure relates to immunoglobulins that exhibit reduced aggregation and includes compositions, methods of generating such immunoglobulins using computational tools, and methods of utilizing these immunoglobulins in the treatment and prevention of diseases.
Career Highlights
Vladimir has worked with leading organizations such as Novartis AG and the Massachusetts Institute of Technology. His work in these institutions has allowed him to push the boundaries of protein engineering and contribute to advancements in therapeutic applications.
Collaborations
Throughout his career, Vladimir has collaborated with notable colleagues, including Naresh Chennamsetty and Bernhard Helk. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Vladimir Voynov's innovative work in protein engineering has led to significant advancements in the understanding and manipulation of proteins. His contributions are vital for the development of new therapeutic strategies and continue to impact the field positively.